Direct Inject 79-45903Recalls & reported problems
Stryker Leibinger GmbH & Co. KG · DirectInject On-Demand HA Cement · Class 2 · Implant
All models of Direct Inject (3)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 07613327123371), received between Feb 27, 2020 and Nov 5, 2020 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Fracture” (1 report).
1 other recall cover devices cleared under the same FDA submission (K143661); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Fracture1
- Material Erosion1
Patient problems
- Impaired Healing1
- Inadequate Osseointegration1
- No Consequences Or Impact To Patient1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryNov 5, 2020Material Erosion; Material Erosion
IT WAS REPORTED THAT A PATIENT UNDERWENT A POSTERIOR CRANIAL CRANIOTOMY DURING ACOUSTIC SCHWANNOMA REMOVAL SURGERY. A COUPLE WEEKS LATER, LUMBAR SPINE DRAINAGE WAS PERFORMED BECAUSE CEREBROSPINAL FLUID LEAKAGE WAS CONFIRMED FROM THE POSTOPERATIVE WOUND. THE LUMBAR DRAINAGE ELIMINATED THE CSF LEAKAGE, BUT THE BONE CEMENT HAD SOLIDIFIED INSIDE THE SCALP WOUND, HINDERING SPONTANEOUS HEALING. AS A RESULT, A FOLLOW UP SURGERY WAS PERFORMED TO REMOVE THE SUBCUTANEOUS CEMENT AND TREAT WOUNDS.
Patient problems: Impaired Healing; Inadequate Osseointegration
MAUDE report 10793120 ↗MalfunctionFeb 27, 2020Fracture; Fracture
IT WAS REPORTED BY THE HEALTH PROFESSIONAL THAT DURING THE SURGERY IT WAS NOTICED THE SYRINGE WAS BROKEN.
Patient problems: No Consequences Or Impact To Patient; No Known Impact Or Consequence To Patient
MAUDE report 9764755 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K143661. One submission often covers many models, so check the product and lot details in each record.
- Z-1436-2021 · Apr 1, 2021 · TerminatedDirectInject consists of a sterile dual paste system which is calcium phosphate based. Upon injection through the Mixer-Cannula, the two pastes form a cement paste which is moldabl
Other METHYL METHACRYLATE FOR CRANIOPLASTY devices
- Direct Inject 79-45905Stryker Leibinger GmbH & Co. KG · METHYL METHACRYLATE FOR CRANIOPLASTY1 recall7 reports
- CRANIOS Reinforced 615.05.01SSynthes GmbH · METHYL METHACRYLATE FOR CRANIOPLASTY17 reports
- CRANIOS Reinforced 615.10.01SSynthes GmbH · METHYL METHACRYLATE FOR CRANIOPLASTY11 reports
- Direct Inject 79-45910Stryker Leibinger GmbH & Co. KG · METHYL METHACRYLATE FOR CRANIOPLASTY7 reports
- HYDROSET 79-43910Stryker Leibinger GmbH & Co. KG · METHYL METHACRYLATE FOR CRANIOPLASTY4 reports
- CRANIOS Reinforced 615.03.01SSynthes GmbH · METHYL METHACRYLATE FOR CRANIOPLASTY4 reports
- StaGraft DBM Putty 92-2004Biomet Orthopedics, LLC · Methyl Methacrylate For Cranioplasty3 reports
- HYDROSET 79-43905Stryker Leibinger GmbH & Co. KG · METHYL METHACRYLATE FOR CRANIOPLASTY2 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page